Literature DB >> 14000867

Leukocyte debranching enzyme in glycogen storage disease.

H E WILLIAMS, E M KENDIG, J B FIELD.   

Abstract

Keywords:  GLUCOSIDASE; GLYCOGENOSIS; LEUKOCYTES

Mesh：

Substances：

Year:  1963        PMID： 14000867      PMCID： PMC289330          DOI： 10.1172/JCI104756

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  9 in total

1.  Low leukocyte phosphorylase in hepatic phosphorylase-deficient glycogen storage disease.

Authors:  H E WILLIAMS; J B FIELD
Journal:  J Clin Invest       Date:  1961-10       Impact factor: 14.808

2.  Phosphorylase activity in leucocytes from patients with glycogen-storages disease.

Authors:  W C HULSMANN; T L OEI
Journal:  Lancet       Date:  1961-09-09       Impact factor: 79.321

3.  Diseases of glycogen storage with special reference to the cardiac type of generalized glycogenosis.

Authors:  P A DI SANT'AGNESE
Journal:  Ann N Y Acad Sci       Date:  1959-02-06       Impact factor: 5.691

4.  Familial cirrhosis of the liver with storage of abnormal glycogen.

Authors:  D H ANDERSEN
Journal:  Lab Invest       Date:  1956 Jan-Feb       Impact factor: 5.662

5.  Studies on the fibrinogen, dextran and phytohemagglutinin methods of isolating leukocytes.

Authors:  W A SKOOG; W S BECK
Journal:  Blood       Date:  1956-05       Impact factor: 22.113

6.  Glucose-6-phosphatase of the liver in glycogen storage disease.

Authors:  G T CORI; C F CORI
Journal:  J Biol Chem       Date:  1952-12       Impact factor: 5.157

7.  GLYCOGEN SYNTHESIS IN MUSCLE LACKING PHOSPHORYLASE.

Authors:  R Schmid; P W Robbins; R R Traut
Journal:  Proc Natl Acad Sci U S A       Date:  1959-08       Impact factor: 11.205

8.  A FUNCTIONAL DISORDER OF MUSCLE ASSOCIATED WITH THE ABSENCE OF PHOSPHORYLASE.

Authors:  W F Mommaerts; B Illingworth; C M Pearson; R J Guillory; K Seraydarian
Journal:  Proc Natl Acad Sci U S A       Date:  1959-06       Impact factor: 11.205

9.  Structure of glycogens and amylopectins. III. Normal and abnormal human glycogen.

Authors:  B ILLINGWORTH; G T CORI
Journal:  J Biol Chem       Date:  1952-12       Impact factor: 5.157
  9 in total
  10 in total

Review 1.  [ON THE ROLE OF BLOOD CELLS IN THE DIAGNOSIS OF HEREDITARY METABOLIC DISEASES].

Authors:  F LINNEWEH
Journal:  Klin Wochenschr       Date:  1963-10-01

2.  STUDIES IN GLYCOGEN STORAGE DISEASES. I. INTESTINAL GLUCOSE-6-PHOSPHATASE ACTIVITY IN PATIENTS WITH VON GIERKE'S DISEASE AND THEIR PARENTS.

Authors:  J B FIELD; S EPSTEIN; T EGAN
Journal:  J Clin Invest       Date:  1965-07       Impact factor: 14.808

3.  A female case of type VIII glycogenosis who developed cirrhosis of the liver and hepatocellular tumor.

Authors:  S Shiomi; Y Saeki; K Kim; S Nishiguchi; S Seki; T Kuroki; K Kobayashi; S Harihara; M Owada
Journal:  Gastroenterol Jpn       Date:  1989-12

4.  Enzyme studies on white blood cells and their significance for genetics.

Authors:  R Wagner
Journal:  Indian J Pediatr       Date:  1971-03       Impact factor: 1.967

5.  Type 3 a glycogenosis. A biochemical and ultrastructural study.

Authors:  F M Paluello; C B Bruni; H Spiele
Journal:  Virchows Arch Pathol Anat Physiol Klin Med       Date:  1967

6.  Alpha-D-glucosidase in normal and leukemic lymphocytes.

Authors:  S A Lisker; J I Brody
Journal:  Experientia       Date:  1968-07-15

7.  Glycogen storage disease type IV, amylopectinosis.

Authors:  B Levin; E A Burgess; P E Mortimer
Journal:  Arch Dis Child       Date:  1968-10       Impact factor: 3.791

8.  Value of the glucagon test in screening for hepatic glycogen storage disease.

Authors:  D B Dunger; J V Leonard
Journal:  Arch Dis Child       Date:  1982-05       Impact factor: 3.791

9.  Growth and endocrine changes in the hepatic glycogenoses.

Authors:  D B Dunger; A T Holder; J V Leonard; J Okae; M A Preece
Journal:  Eur J Pediatr       Date:  1982-05       Impact factor: 3.183

10.  Myopathies due to enzyme deficiencies.

Authors:  F Cornelio; S Di Donato
Journal:  J Neurol       Date:  1985       Impact factor: 4.849
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.